The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Hematoma growth and outcomes in intracerebral hemorrhage: The INTERACT1 study
Abstract
OBJECTIVE: Uncertainty exists over the size of potential beneficial effects of medical treatments targeting hematoma growth in intracerebral hemorrhage (ICH). We report associations of hematoma growth parameters on clinical outcomes in the pilot phase, Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT1) (ClinicalTrials.gov NCT00226096). METHODS: In randomized patients with both baseline and 24-hour brain CT (n = 335), associations between measures of absolute and relative hematoma growth and 90-day poor outcomes of death and dependency (modified Rankin Scale score 3-5) were assessed in logistic regression models, with data reported as odds ratios (OR) and 95% confidence intervals (CI). RESULTS: A total of 10.7 mL (1 SD) increase in hematoma volume over 24 hours was strongly associated with poor outcome (adjusted OR 1.72, 95% CI 1.19-2.49; p = 0.004). An association was also evident for relative growth (adjusted OR 1.67, 95% 1.22-2.27; p = 0.001 for 1 SD increase). The analyses were adjusted for age, sex, achieved systolic blood pressure, elevated NIH Stroke Scale score (≥ 14), hematoma location, baseline hematoma volume, intraventricular extension, antithrombotic therapy, baseline glucose, time from ICH to baseline CT scan, and time from baseline to repeat CT scan. A 1 mL increase in hematoma growth was associated with a 5% (95% CI 2%-9%) higher risk of death or dependency. CONCLUSION: Medical treatments, such as rapid intensive blood pressure lowering, could achieve ∼2-4 mL absolute attenuation of hematoma growth. There is hope that this could translate into modest but still clinically worthwhile (∼10%-20% better chance) outcome from ICH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spontaneous intracerebral hemorrhage
Qureshi, A. I., Tuhrim, S., Broderick, J. P., Batjer, H. H., Hondo, H., & Hanley, D. F. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441907 · Cited by 1,719
Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
Mayer, S. A., Brun, N. C., Begtrup, K., Broderick, J., Davis, S., Diringer, M. N., Skolnick, B. E., & Steiner, T. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707534 · Cited by 1,255
Self-citation
Metadata
- Authors
- Delcourt, C., Huang, Y., Arima, H., Chalmers, J., Davis, S. M., Heeley, E. L., Wang, J., Parsons, M. W., Liu, G., Anderson, C. S., Chalmers, J., Anderson, C. S., Huang, Y., Wang, J., Arima, H., Bath, P., Davis, S., Kim, J., Lindley, R., Neal, B., Morgenstern, L. B., MacMahon, S., Woodward, M., Bladin, C., Lueck, C., Levi, C., Corbett, A., Davis, S., Blacker, D., Chambers, B., Sturm, J., Tao, Q., Li, Y., Dong, J., Tai, L., Zhang, J., Xu, E., Cheng, Y., Wang, S., Liu, J., Tan, X., Wang, N., Dong, Q., Liu, C., Sun, J., Sun, X., He, M., Miao, L., Sun, Y., Ding, S., Zhang, W., Chen, S., Liu, Z., Qi, X., Huang, Y., Jiang, Y., FengJilin, J., Di, Q., Li, W., Li, X., Fan, D., Gao, X., Wong, K. S. L., Cho, K. H., Bae, H. J., Yoon, B. W., & Kim, J. S.
- Venue
- Neurology
- Published
- 2012-07-24
- Volume
- 79
- Issue
- 4
- Pages
- 314-319
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2154438850
- Cited by
- 261
- References
- 2
- FWCI
- 8.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hematoma growth and outcomes in intracerebral hemorrhage: The INTERACT1 study. https://app.cochat.ai/papers/10.1212/wnl.0b013e318260cbba
- The paper
- Delcourt, C., Huang, Y., Arima, H., Chalmers, J., Davis, S. M., Heeley, E. L., Wang, J., Parsons, M. W., Liu, G., Anderson, C. S., Chalmers, J., Anderson, C. S., Huang, Y., Wang, J., Arima, H., Bath, P., Davis, S., Kim, J., Lindley, R., . . . Kim, J. S. (2012). Hematoma growth and outcomes in intracerebral hemorrhage: The INTERACT1 study. Neurology. https://doi.org/10.1212/wnl.0b013e318260cbba
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
